News Center

Home > NEWS CENTER

PRESS RELEASES

05/16/2013
SIMPONI® (GOLIMUMAB) RECEIVES FDA APPROVAL FOR ULCERATIVE COLITIS
04/18/2013
Richard Petty Teams Up With Janssen Biotech to Launch Show Your Stripes for Prostate Cancer Awareness
04/08/2013
Ibrutinib Receives Third Oncology Breakthrough Therapy Designation from U.S. Food and Drug Administration
02/12/2013
Follow-up Data Show ZYTIGA® Plus Prednisone Continues to Delay Progression of Metastatic Castration-Resistant Prostate Cancer in Patients without Prior Chemotherapy
02/12/2013
Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
12/10/2012
U.S. FDA APPROVES EXPANDED ZYTIGA® INDICATION FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
12/06/2012
JANSSEN SUBMITS APPLICATIONS REQUESTING APPROVAL OF STELARA® IN U.S. AND EUROPE FOR TREATMENT OF ACTIVE PSORIATIC ARTHRITIS
11/12/2012
NEW PHASE 3 FINDINGS SHOW STELARA® SIGNIFICANTLY REDUCED SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS
11/12/2012
PHASE 3 DATA SHOW INTRAVENOUS GOLIMUMAB INHIBITED RADIOGRAPHIC PROGRESSION IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
11/08/2012
WHAT MEN SHOULD KNOW ABOUT PROSTATE CANCER – BUT DON’T
10/22/2012
NEW ONE-YEAR PHASE 3 STUDY RESULTS SHOW ANTI-TNF SIMPONI® MAINTAINED CLINICAL RESPONSE IN TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
10/17/2012
CROHN’S DISEASE PATIENTS REFRACTORY TO TUMOR NECROSIS FACTOR INHIBITORS SHOWED IMPROVEMENT IN DISEASE WITH STELARA® TREATMENT
10/01/2012
JANSSEN ANNOUNCES WORLDWIDE AGREEMENT TO DEVELOP AND COMMERCIALIZE JAK INHIBITOR FOR IMMUNOLOGICAL DISEASES
09/30/2012
NEW ZYTIGA® (ABIRATERONE ACETATE) DATA ON PAIN AND FUNCTION PRESENTED AT THE ESMO 2012 CONGRESS(EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY)
09/18/2012
JANSSEN SUBMITS APPLICATION TO FDA REQUESTING APPROVAL OF SIMPONI® INTRAVENOUS FORMULATION FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS
08/30/2012
JANSSEN BIOTECH ANNOUNCES GLOBAL LICENSE AND DEVELOPMENT AGREEMENT FOR INVESTIGATIONAL ANTI-CANCER AGENT DARATUMUMAB
08/29/2012
U.S. FDA GRANTS PRIORITY REVIEW OF ZYTIGA® (ABIRATERONE ACETATE) SNDA FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER BEFORE CHEMOTHERAPY
07/16/2012
JANSSEN SUBMITS APPLICATIONS REQUESTING APPROVAL OF SIMPONI® IN U.S. AND EUROPE FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
06/25/2012
SEASON 10 AMERICAN IDOL FINALIST AND MUSICIAN CASEY ABRAMS RELEASES NEW SONG DEVOTED TO RAISING AWARENESS ABOUT INFLAMMATORY BOWEL DISEASE